インシュリン様成長因子Iの世界市場（～2026年）

• 英文タイトル：Global Insulin Like Growth Factor I Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01756
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、116ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はインシュリン様成長因子Iのグローバル市場について調査・分析したレポートです。種類別（CIGB-845、Dusigitumab、GM-6、M-610.27、M-630、その他）市場規模、用途別（アルツハイマー病、乳がん、ハンチントン病、筋ジストロフィー、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別インシュリン様成長因子Iの競争状況、市場シェア
・世界のインシュリン様成長因子I市場：種類別市場規模 2015年-2020年（CIGB-845、Dusigitumab、GM-6、M-610.27、M-630、その他）
・世界のインシュリン様成長因子I市場：種類別市場規模予測 2021年-2026年（CIGB-845、Dusigitumab、GM-6、M-610.27、M-630、その他）
・世界のインシュリン様成長因子I市場：用途別市場規模 2015年-2020年（アルツハイマー病、乳がん、ハンチントン病、筋ジストロフィー、その他）
・世界のインシュリン様成長因子I市場：用途別市場規模予測 2021年-2026年（アルツハイマー病、乳がん、ハンチントン病、筋ジストロフィー、その他）
・北米のインシュリン様成長因子I市場分析：米国、カナダ
・ヨーロッパのインシュリン様成長因子I市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのインシュリン様成長因子I市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のインシュリン様成長因子I市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのインシュリン様成長因子I市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Boehringer Ingelheim GmbH、Genervon Biopharmaceuticals LLC、MedImmune LLC、Regulaxis SAS
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Insulin Like Growth Factor I Market
The global Insulin Like Growth Factor I market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Insulin Like Growth Factor I Scope and Market Size
Insulin Like Growth Factor I market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Like Growth Factor I market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Insulin Like Growth Factor I market is segmented into
CIGB-845
Dusigitumab
GM-6
M-610.27
M-630
Others

Segment by Application, the Insulin Like Growth Factor I market is segmented into
Alzheimer’s Disease
Breast Cancer
Huntington Disease
Muscular Dystrophy
Others

Regional and Country-level Analysis
The Insulin Like Growth Factor I market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Like Growth Factor I market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insulin Like Growth Factor I Market Share Analysis
Insulin Like Growth Factor I market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Like Growth Factor I business, the date to enter into the Insulin Like Growth Factor I market, Insulin Like Growth Factor I product introduction, recent developments, etc.

The major vendors covered:
Boehringer Ingelheim GmbH
Genervon Biopharmaceuticals LLC
MedImmune LLC
Regulaxis SAS
…

レポート目次

1 Study Coverage
1.1 Insulin Like Growth Factor I Product Introduction
1.2 Market Segments
1.3 Key Insulin Like Growth Factor I Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin Like Growth Factor I Market Size Growth Rate by Type
1.4.2 CIGB-845
1.4.3 Dusigitumab
1.4.4 GM-6
1.4.5 M-610.27
1.4.6 M-630
1.4.7 Others
1.5 Market by Application
1.5.1 Global Insulin Like Growth Factor I Market Size Growth Rate by Application
1.5.2 Alzheimer’s Disease
1.5.3 Breast Cancer
1.5.4 Huntington Disease
1.5.5 Muscular Dystrophy
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Insulin Like Growth Factor I Market Size, Estimates and Forecasts
2.1.1 Global Insulin Like Growth Factor I Revenue 2015-2026
2.1.2 Global Insulin Like Growth Factor I Sales 2015-2026
2.2 Global Insulin Like Growth Factor I, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Insulin Like Growth Factor I Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insulin Like Growth Factor I Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Insulin Like Growth Factor I Competitor Landscape by Players
3.1 Insulin Like Growth Factor I Sales by Manufacturers
3.1.1 Insulin Like Growth Factor I Sales by Manufacturers (2015-2020)
3.1.2 Insulin Like Growth Factor I Sales Market Share by Manufacturers (2015-2020)
3.2 Insulin Like Growth Factor I Revenue by Manufacturers
3.2.1 Insulin Like Growth Factor I Revenue by Manufacturers (2015-2020)
3.2.2 Insulin Like Growth Factor I Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Like Growth Factor I Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin Like Growth Factor I Revenue in 2019
3.2.5 Global Insulin Like Growth Factor I Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insulin Like Growth Factor I Price by Manufacturers
3.4 Insulin Like Growth Factor I Manufacturing Base Distribution, Product Types
3.4.1 Insulin Like Growth Factor I Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Like Growth Factor I Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Like Growth Factor I Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Insulin Like Growth Factor I Market Size by Type (2015-2020)
4.1.1 Global Insulin Like Growth Factor I Sales by Type (2015-2020)
4.1.2 Global Insulin Like Growth Factor I Revenue by Type (2015-2020)
4.1.3 Insulin Like Growth Factor I Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin Like Growth Factor I Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin Like Growth Factor I Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Like Growth Factor I Revenue Forecast by Type (2021-2026)
4.2.3 Insulin Like Growth Factor I Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin Like Growth Factor I Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Insulin Like Growth Factor I Market Size by Application (2015-2020)
5.1.1 Global Insulin Like Growth Factor I Sales by Application (2015-2020)
5.1.2 Global Insulin Like Growth Factor I Revenue by Application (2015-2020)
5.1.3 Insulin Like Growth Factor I Price by Application (2015-2020)
5.2 Insulin Like Growth Factor I Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin Like Growth Factor I Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Like Growth Factor I Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Like Growth Factor I Price Forecast by Application (2021-2026)

6 North America
6.1 North America Insulin Like Growth Factor I by Country
6.1.1 North America Insulin Like Growth Factor I Sales by Country
6.1.2 North America Insulin Like Growth Factor I Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insulin Like Growth Factor I Market Facts & Figures by Type
6.3 North America Insulin Like Growth Factor I Market Facts & Figures by Application

7 Europe
7.1 Europe Insulin Like Growth Factor I by Country
7.1.1 Europe Insulin Like Growth Factor I Sales by Country
7.1.2 Europe Insulin Like Growth Factor I Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Like Growth Factor I Market Facts & Figures by Type
7.3 Europe Insulin Like Growth Factor I Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Insulin Like Growth Factor I by Region
8.1.1 Asia Pacific Insulin Like Growth Factor I Sales by Region
8.1.2 Asia Pacific Insulin Like Growth Factor I Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insulin Like Growth Factor I Market Facts & Figures by Type
8.3 Asia Pacific Insulin Like Growth Factor I Market Facts & Figures by Application

9 Latin America
9.1 Latin America Insulin Like Growth Factor I by Country
9.1.1 Latin America Insulin Like Growth Factor I Sales by Country
9.1.2 Latin America Insulin Like Growth Factor I Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insulin Like Growth Factor I Market Facts & Figures by Type
9.3 Central & South America Insulin Like Growth Factor I Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Insulin Like Growth Factor I by Country
10.1.1 Middle East and Africa Insulin Like Growth Factor I Sales by Country
10.1.2 Middle East and Africa Insulin Like Growth Factor I Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Insulin Like Growth Factor I Market Facts & Figures by Type
10.3 Middle East and Africa Insulin Like Growth Factor I Market Facts & Figures by Application

11 Company Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Corporation Information
11.1.2 Boehringer Ingelheim GmbH Description and Business Overview
11.1.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Products Offered
11.1.5 Boehringer Ingelheim GmbH Related Developments
11.2 Genervon Biopharmaceuticals LLC
11.2.1 Genervon Biopharmaceuticals LLC Corporation Information
11.2.2 Genervon Biopharmaceuticals LLC Description and Business Overview
11.2.3 Genervon Biopharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Products Offered
11.2.5 Genervon Biopharmaceuticals LLC Related Developments
11.3 MedImmune LLC
11.3.1 MedImmune LLC Corporation Information
11.3.2 MedImmune LLC Description and Business Overview
11.3.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 MedImmune LLC Insulin Like Growth Factor I Products Offered
11.3.5 MedImmune LLC Related Developments
11.4 Regulaxis SAS
11.4.1 Regulaxis SAS Corporation Information
11.4.2 Regulaxis SAS Description and Business Overview
11.4.3 Regulaxis SAS Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Regulaxis SAS Insulin Like Growth Factor I Products Offered
11.4.5 Regulaxis SAS Related Developments
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Corporation Information
11.1.2 Boehringer Ingelheim GmbH Description and Business Overview
11.1.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Products Offered
11.1.5 Boehringer Ingelheim GmbH Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insulin Like Growth Factor I Market Estimates and Projections by Region
12.1.1 Global Insulin Like Growth Factor I Sales Forecast by Regions 2021-2026
12.1.2 Global Insulin Like Growth Factor I Revenue Forecast by Regions 2021-2026
12.2 North America Insulin Like Growth Factor I Market Size Forecast (2021-2026)
12.2.1 North America: Insulin Like Growth Factor I Sales Forecast (2021-2026)
12.2.2 North America: Insulin Like Growth Factor I Revenue Forecast (2021-2026)
12.2.3 North America: Insulin Like Growth Factor I Market Size Forecast by Country (2021-2026)
12.3 Europe Insulin Like Growth Factor I Market Size Forecast (2021-2026)
12.3.1 Europe: Insulin Like Growth Factor I Sales Forecast (2021-2026)
12.3.2 Europe: Insulin Like Growth Factor I Revenue Forecast (2021-2026)
12.3.3 Europe: Insulin Like Growth Factor I Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insulin Like Growth Factor I Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insulin Like Growth Factor I Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insulin Like Growth Factor I Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insulin Like Growth Factor I Market Size Forecast by Region (2021-2026)
12.5 Latin America Insulin Like Growth Factor I Market Size Forecast (2021-2026)
12.5.1 Latin America: Insulin Like Growth Factor I Sales Forecast (2021-2026)
12.5.2 Latin America: Insulin Like Growth Factor I Revenue Forecast (2021-2026)
12.5.3 Latin America: Insulin Like Growth Factor I Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insulin Like Growth Factor I Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insulin Like Growth Factor I Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insulin Like Growth Factor I Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insulin Like Growth Factor I Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Insulin Like Growth Factor I Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Like Growth Factor I Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Insulin Like Growth Factor I Market Segments
Table 2. Ranking of Global Top Insulin Like Growth Factor I Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Like Growth Factor I Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CIGB-845
Table 5. Major Manufacturers of Dusigitumab
Table 6. Major Manufacturers of GM-6
Table 7. Major Manufacturers of M-610.27
Table 8. Major Manufacturers of M-630
Table 9. Major Manufacturers of Others
Table 10. Global Insulin Like Growth Factor I Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Insulin Like Growth Factor I Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Insulin Like Growth Factor I Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Insulin Like Growth Factor I Sales Market Share by Regions (2015-2020)
Table 14. Global Insulin Like Growth Factor I Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Insulin Like Growth Factor I Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Insulin Like Growth Factor I Sales Share by Manufacturers (2015-2020)
Table 17. Global Insulin Like Growth Factor I Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Insulin Like Growth Factor I by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Like Growth Factor I as of 2019)
Table 19. Insulin Like Growth Factor I Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Insulin Like Growth Factor I Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Insulin Like Growth Factor I Price (2015-2020) (USD/Pcs)
Table 22. Insulin Like Growth Factor I Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Insulin Like Growth Factor I Product Type
Table 24. Date of International Manufacturers Enter into Insulin Like Growth Factor I Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Insulin Like Growth Factor I Sales by Type (2015-2020) (K Pcs)
Table 27. Global Insulin Like Growth Factor I Sales Share by Type (2015-2020)
Table 28. Global Insulin Like Growth Factor I Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Insulin Like Growth Factor I Revenue Share by Type (2015-2020)
Table 30. Insulin Like Growth Factor I Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Insulin Like Growth Factor I Sales by Application (2015-2020) (K Pcs)
Table 32. Global Insulin Like Growth Factor I Sales Share by Application (2015-2020)
Table 33. North America Insulin Like Growth Factor I Sales by Country (2015-2020) (K Pcs)
Table 34. North America Insulin Like Growth Factor I Sales Market Share by Country (2015-2020)
Table 35. North America Insulin Like Growth Factor I Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Insulin Like Growth Factor I Revenue Market Share by Country (2015-2020)
Table 37. North America Insulin Like Growth Factor I Sales by Type (2015-2020) (K Pcs)
Table 38. North America Insulin Like Growth Factor I Sales Market Share by Type (2015-2020)
Table 39. North America Insulin Like Growth Factor I Sales by Application (2015-2020) (K Pcs)
Table 40. North America Insulin Like Growth Factor I Sales Market Share by Application (2015-2020)
Table 41. Europe Insulin Like Growth Factor I Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Insulin Like Growth Factor I Sales Market Share by Country (2015-2020)
Table 43. Europe Insulin Like Growth Factor I Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Insulin Like Growth Factor I Revenue Market Share by Country (2015-2020)
Table 45. Europe Insulin Like Growth Factor I Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Insulin Like Growth Factor I Sales Market Share by Type (2015-2020)
Table 47. Europe Insulin Like Growth Factor I Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Insulin Like Growth Factor I Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Insulin Like Growth Factor I Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Insulin Like Growth Factor I Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Insulin Like Growth Factor I Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Insulin Like Growth Factor I Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Insulin Like Growth Factor I Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Insulin Like Growth Factor I Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Insulin Like Growth Factor I Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Insulin Like Growth Factor I Sales Market Share by Application (2015-2020)
Table 57. Latin America Insulin Like Growth Factor I Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Insulin Like Growth Factor I Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Insulin Like Growth Factor I Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Insulin Like Growth Factor I Revenue Market Share by Country (2015-2020)
Table 61. Latin America Insulin Like Growth Factor I Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Insulin Like Growth Factor I Sales Market Share by Type (2015-2020)
Table 63. Latin America Insulin Like Growth Factor I Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Insulin Like Growth Factor I Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Insulin Like Growth Factor I Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Insulin Like Growth Factor I Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Insulin Like Growth Factor I Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Insulin Like Growth Factor I Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Insulin Like Growth Factor I Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Application (2015-2020)
Table 73. Boehringer Ingelheim GmbH Corporation Information
Table 74. Boehringer Ingelheim GmbH Description and Major Businesses
Table 75. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Boehringer Ingelheim GmbH Product
Table 77. Boehringer Ingelheim GmbH Recent Development
Table 78. Genervon Biopharmaceuticals LLC Corporation Information
Table 79. Genervon Biopharmaceuticals LLC Description and Major Businesses
Table 80. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Genervon Biopharmaceuticals LLC Product
Table 82. Genervon Biopharmaceuticals LLC Recent Development
Table 83. MedImmune LLC Corporation Information
Table 84. MedImmune LLC Description and Major Businesses
Table 85. MedImmune LLC Insulin Like Growth Factor I Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. MedImmune LLC Product
Table 87. MedImmune LLC Recent Development
Table 88. Regulaxis SAS Corporation Information
Table 89. Regulaxis SAS Description and Major Businesses
Table 90. Regulaxis SAS Insulin Like Growth Factor I Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Regulaxis SAS Product
Table 92. Regulaxis SAS Recent Development
Table 93. Global Insulin Like Growth Factor I Sales Forecast by Regions (2021-2026) (K Pcs)
Table 94. Global Insulin Like Growth Factor I Sales Market Share Forecast by Regions (2021-2026)
Table 95. Global Insulin Like Growth Factor I Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 96. Global Insulin Like Growth Factor I Revenue Market Share Forecast by Regions (2021-2026)
Table 97. North America: Insulin Like Growth Factor I Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. North America: Insulin Like Growth Factor I Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Europe: Insulin Like Growth Factor I Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. Europe: Insulin Like Growth Factor I Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Asia Pacific: Insulin Like Growth Factor I Sales Forecast by Region (2021-2026) (K Pcs)
Table 102. Asia Pacific: Insulin Like Growth Factor I Revenue Forecast by Region (2021-2026) (US$ Million)
Table 103. Latin America: Insulin Like Growth Factor I Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Latin America: Insulin Like Growth Factor I Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Middle East and Africa: Insulin Like Growth Factor I Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. Middle East and Africa: Insulin Like Growth Factor I Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 108. Key Challenges
Table 109. Market Risks
Table 110. Main Points Interviewed from Key Insulin Like Growth Factor I Players
Table 111. Insulin Like Growth Factor I Customers List
Table 112. Insulin Like Growth Factor I Distributors List
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Like Growth Factor I Product Picture
Figure 2. Global Insulin Like Growth Factor I Sales Market Share by Type in 2020 & 2026
Figure 3. CIGB-845 Product Picture
Figure 4. Dusigitumab Product Picture
Figure 5. GM-6 Product Picture
Figure 6. M-610.27 Product Picture
Figure 7. M-630 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Insulin Like Growth Factor I Sales Market Share by Application in 2020 & 2026
Figure 10. Alzheimer's Disease
Figure 11. Breast Cancer
Figure 12. Huntington Disease
Figure 13. Muscular Dystrophy
Figure 14. Others
Figure 15. Insulin Like Growth Factor I Report Years Considered
Figure 16. Global Insulin Like Growth Factor I Market Size 2015-2026 (US$ Million)
Figure 17. Global Insulin Like Growth Factor I Sales 2015-2026 (K Pcs)
Figure 18. Global Insulin Like Growth Factor I Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Insulin Like Growth Factor I Sales Market Share by Region (2015-2020)
Figure 20. Global Insulin Like Growth Factor I Sales Market Share by Region in 2019
Figure 21. Global Insulin Like Growth Factor I Revenue Market Share by Region (2015-2020)
Figure 22. Global Insulin Like Growth Factor I Revenue Market Share by Region in 2019
Figure 23. Global Insulin Like Growth Factor I Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Insulin Like Growth Factor I Revenue in 2019
Figure 25. Insulin Like Growth Factor I Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Insulin Like Growth Factor I Sales Market Share by Type (2015-2020)
Figure 27. Global Insulin Like Growth Factor I Sales Market Share by Type in 2019
Figure 28. Global Insulin Like Growth Factor I Revenue Market Share by Type (2015-2020)
Figure 29. Global Insulin Like Growth Factor I Revenue Market Share by Type in 2019
Figure 30. Global Insulin Like Growth Factor I Market Share by Price Range (2015-2020)
Figure 31. Global Insulin Like Growth Factor I Sales Market Share by Application (2015-2020)
Figure 32. Global Insulin Like Growth Factor I Sales Market Share by Application in 2019
Figure 33. Global Insulin Like Growth Factor I Revenue Market Share by Application (2015-2020)
Figure 34. Global Insulin Like Growth Factor I Revenue Market Share by Application in 2019
Figure 35. North America Insulin Like Growth Factor I Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Insulin Like Growth Factor I Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Insulin Like Growth Factor I Sales Market Share by Country in 2019
Figure 38. North America Insulin Like Growth Factor I Revenue Market Share by Country in 2019
Figure 39. U.S. Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Insulin Like Growth Factor I Market Share by Type in 2019
Figure 44. North America Insulin Like Growth Factor I Market Share by Application in 2019
Figure 45. Europe Insulin Like Growth Factor I Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Insulin Like Growth Factor I Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Insulin Like Growth Factor I Sales Market Share by Country in 2019
Figure 48. Europe Insulin Like Growth Factor I Revenue Market Share by Country in 2019
Figure 49. Germany Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Insulin Like Growth Factor I Market Share by Type in 2019
Figure 60. Europe Insulin Like Growth Factor I Market Share by Application in 2019
Figure 61. Asia Pacific Insulin Like Growth Factor I Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Insulin Like Growth Factor I Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Insulin Like Growth Factor I Sales Market Share by Region in 2019
Figure 64. Asia Pacific Insulin Like Growth Factor I Revenue Market Share by Region in 2019
Figure 65. China Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Insulin Like Growth Factor I Market Share by Type in 2019
Figure 88. Asia Pacific Insulin Like Growth Factor I Market Share by Application in 2019
Figure 89. Latin America Insulin Like Growth Factor I Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Insulin Like Growth Factor I Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Insulin Like Growth Factor I Sales Market Share by Country in 2019
Figure 92. Latin America Insulin Like Growth Factor I Revenue Market Share by Country in 2019
Figure 93. Mexico Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Insulin Like Growth Factor I Market Share by Type in 2019
Figure 100. Latin America Insulin Like Growth Factor I Market Share by Application in 2019
Figure 101. Middle East and Africa Insulin Like Growth Factor I Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Insulin Like Growth Factor I Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Insulin Like Growth Factor I Revenue Market Share by Country in 2019
Figure 105. Turkey Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Insulin Like Growth Factor I Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Insulin Like Growth Factor I Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Insulin Like Growth Factor I Market Share by Type in 2019
Figure 112. Middle East and Africa Insulin Like Growth Factor I Market Share by Application in 2019
Figure 113. North America Insulin Like Growth Factor I Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Insulin Like Growth Factor I Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Insulin Like Growth Factor I Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Insulin Like Growth Factor I Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Insulin Like Growth Factor I Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Insulin Like Growth Factor I Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Insulin Like Growth Factor I Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Insulin Like Growth Factor I Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Insulin Like Growth Factor I Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Insulin Like Growth Factor I Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed

以下、関連資料のご紹介

インシュリン様成長因子1受容体の世界市場（～2026年）

Global Insulin Like Growth Factor 1 Receptor Market Insights and Forecast to 2026
MRC2-11QY01755 2020年11月20日 148Pages
当調査資料はインシュリン様成長因子1受容体のグローバル市場について調査・分析したレポートです。種類別（BI-893923、CT-707、1R-E1、ATL-1101、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

CISインスリンの世界市場（～2026年）

Global CIS Insulin Market Size, Status and Forecast 2020-2026
MRC2-11QY11381 2020年11月25日 92Pages
当調査資料はCISインスリンのグローバル市場について調査・分析したレポートです。種類別（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン）市場規模、用途別（I型・その他糖尿病、II型糖尿病）市場規模、地域別（北米、米国、カナダ...

第IX因子欠乏症治療の世界市場（～2026年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11918 2020年11月25日 96Pages
当調査資料は第IX因子欠乏症治療のグローバル市場について調査・分析したレポートです。種類別（血友病B、血友病B阻害剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

バイオシミラーインスリンの世界市場（～2026年）

Global Biosimilars Insulin Market Insights and Forecast to 2026
MRC2-11QY03285 2020年11月20日 115Pages
当調査資料はバイオシミラーインスリンのグローバル市場について調査・分析したレポートです。種類別（インスリングラルギンバサグラル、インスリンランタス）市場規模、用途別（I型糖尿病、II型糖尿病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...

インスリンデテミルの世界市場（～2026年）

Global Insulin Detemir Market Insights and Forecast to 2026
MRC2-11QY01753 2020年11月20日 119Pages
当調査資料はインスリンデテミルのグローバル市場について調査・分析したレポートです。種類別（再利用可能、使い捨て）市場規模、用途別（病院、診療所、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

インスリン有効成分の世界市場（～2026年）

Global Insulin Active Pharmaceutical Ingredient Market Insights and Forecast to 2026
MRC2-11QY01752 2020年11月20日 110Pages
当調査資料はインスリン有効成分のグローバル市場について調査・分析したレポートです。種類別（化学合成、動物抽出物）市場規模、用途別（動物インスリン、通常ヒトインスリン、インスリンアナログ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

インスリン薬・デリバリー技術の世界市場（～2026年）

Global Insulin Drug and Delivery Technologies Market Insights and Forecast to 2026
MRC2-11QY01754 2020年11月20日 117Pages
当調査資料はインスリン薬・デリバリー技術のグローバル市場について調査・分析したレポートです。種類別（インスリン注射器、インスリンバイアル、インスリンペン、インスリンポンプ）市場規模、用途別（1型糖尿病、2型糖尿病、妊娠糖尿病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

糖尿病用非インスリン療法の世界市場（～2026年）

Global Non-Insulin Therapies for Diabetes Market Size, Status and Forecast 2020-2026
MRC2-11QY04002 2020年11月20日 128Pages
当調査資料は糖尿病用非インスリン療法のグローバル市場について調査・分析したレポートです。種類別（アルファ-グルコシダーゼ阻害剤、アミリンアゴニスト、ビグアニド、ジペプチジルペプチダーゼ-4（DPP4）阻害剤、グリニド/メグリチニド、GLP-1アナログ/ GLP-1アゴニスト、ナトリウム-グルコース共...

血友病A・B組換え因子補充療法の世界市場（～2026年）

Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, Status and Forecast 2020-2026
MRC2-11QY12158 2020年11月25日 94Pages
当調査資料は血友病A・B組換え因子補充療法のグローバル市場について調査・分析したレポートです。種類別（血友病A、血友病B）市場規模、用途別（病院、クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

インスリンペン針の世界市場（～2026年）

Global Insulin Pen Needle Market Insights and Forecast to 2026
MRC2-11QY01757 2020年11月20日 118Pages
当調査資料はインスリンペン針のグローバル市場について調査・分析したレポートです。種類別（標準インスリンペン針、安全インスリンペン針）市場規模、用途別（家庭用、医療機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

インシュリン様成長因子1受容体の世界市場（～2026年） Market Analysis and Insights: Global Insulin Like Growth Factor 1 Receptor Market The global Insulin Like Growth Factor 1 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Like Growth Factor 1 Receptor S…
CISインスリンの世界市場（～2026年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…
第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
インスリンデテミルの世界市場（～2026年） Market Analysis and Insights: Global Insulin Detemir Market The global Insulin Detemir market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Detemir Scope and Market Size Insulin Detemir market is segmented by Type, …